Daniel Smith MD in Little Rock, Arkansas

Medical School: University Of Arkansas College Of Medicine
Graduation Year: 1996
The Primary Medical Specialty for Daniel Smith MD is listed as: Dermatology
Credentials: MD
Additional Credentials:
Approximate Years of Experience: 28
PAC (PECOS ID)#: 5395728976
NPI #: 1912992843
NPI Created On: 09/16/2005
NPI Last Updated Listed as: 10/28/2020
Primary Taxonomy Code: 207N00000X
License Number:
L1754
Listed Gender: Male

Forms of insurance accepted by include, but are not limited to:

• Ambetter
• QualChoice Life & Health Insurance Company, Inc.
• USAble Mutual Insurance Company
• Humana
• Medicare

They are listed as accepting new patients.

Languages spoken by staff include: English, ENGL.

Services and Procedures include:

1. Tangential biopsy of single skin lesion
2. Tangential biopsy of additional skin lesion
3. Punch biopsy of single skin lesion
4. Shaving of 0.5 centimeters or less skin growth of the trunk, arms, or legs
5. Shaving of 0.6 centimeters to 1.0 centimeters skin growth of the trunk, arms, or legs
6. Shaving of 1.1 to 2.0 centimeters skin growth of the trunk, arms, or legs
7. Shaving of 0.5 centimeters or less skin growth of scalp, neck, hands, feet, or genitals
8. Shaving of 0.6 centimeters to 1.0 centimeters skin growth of scalp, neck, hands, feet, or genitals
9. Shaving of 1.1 to 2.0 centimeters skin growth of scalp, neck, hands, feet, or genitals
10. Shaving of 0.5 centimeters or less skin growth of face, ears, eyelids, nose, lips, or mouth
11. Shaving of 0.6 centimeters to 1.0 centimeters skin growth of face, ears, eyelids, nose, lips, or mouth
12. Shaving of 1.1 to 2.0 centimeters skin growth of face, ears, eyelids, nose, lips, or mouth
13. Destruction of skin growth
14. Destruction of 2-14 skin growths
15. Destruction of up to 14 skin growths
16. Destruction of malignant growth (1.1 to 2.0 centimeters) of trunk, arms, or legs
17. Destruction of malignant growth (1.1 to 2.0 centimeters) of scalp, neck, hands, feet, or genitals
18. Destruction of malignant growth (0.6 to 1.0 centimeters) of face, ears, eyelids, nose, lips, or mouth
19. Destruction of malignant growth (1.1 to 2.0 centimeters) of face, ears, eyelids, nose, lips, or mouth
20. Biopsy of ear